Effects of fish oil supplementation on the fatty acid profile in erythrocyte membrane and plasma phospholipids of pregnant women and their offspring: a randomised controlled trial
Authors:
- Cristina CampoyCristina Campoy
- M. Carmen Ramírez-TortosaMRM. Carmen Ramírez-Tortosa
- Hans DemmelmairHDHans Demmelmair
- M. Teresa MirandaMMM. Teresa Miranda
- Angel GilAGAngel Gil
- Tamás DecsiTDTamás Decsi
- Berthold V. KoletzkoBKBerthold V. Koletzko
- 5 September 2012
- journal article
- research article
- Published by Cambridge University Press (CUP) in British Journal of Nutrition
- Vol. 109 (9) , 1647-1656
Abstract
We aimed to investigate the effects of fish oil (FO) supplementation to pregnant women on the maternal and fetal fatty acid profile in plasma and erythrocyte phospholipids (PL) and to identify the best compartment for the assessment of fatty acid status. A multi-centre, double-blind, controlled trial was conducted. Healthy pregnant women from three European centres were randomly assigned to receive from week 20 of gestation until delivery a daily dietary supplement with either FO (500 mg DHA+150 mg EPA), 400 μg 5-methyltetrahydrofolate, both or placebo. Fatty acids in plasma and erythrocyte PL were determined in maternal blood (week 20, week 30 of pregnancy and delivery) and in cord blood (delivery). FO supplementation increased DHA levels in maternal and cord plasma and erythrocyte PL. Higher percentage changes were observed in erythrocyte PL than in plasma PL. There were significant correlations between plasma and erythrocyte fatty acid levels in maternal and cord blood. Significant correlations between maternal and cord fatty acid levels at delivery in plasma and erythrocytes were also observed; however, correlation coefficients were higher for erythrocyte phophatidylethanolamine. FO supplementation increases maternal and fetal DHA status. Both plasma and erythrocytes appear to be suitable to evaluate the fatty acid status of mothers but erythrocytes seem to be a more reliable marker in neonates.Keywords
This publication has 32 references indexed in Scilit:
- Methods of assessment of n–3 long-chain polyunsaturated fatty acid status in humans: a systematic reviewThe American Journal of Clinical Nutrition, 2009
- Dietary Intake of Natural Sources of Docosahexaenoic Acid and Folate in Pregnant Women of Three European CohortsAnnals of Nutrition and Metabolism, 2008
- Supplementation with 200 mg/Day Docosahexaenoic Acid from Mid-Pregnancy through Lactation Improves the Docosahexaenoic Acid Status of Mothers with a Habitually Low Fish Intake and of Their InfantsAnnals of Nutrition and Metabolism, 2008
- Incorporation and Clearance of Omega-3 Fatty Acids in Erythrocyte Membranes and Plasma PhospholipidsClinical Chemistry, 2006
- n− 3 Fatty acid supplementation during pregnancy in women with allergic disease: effects on blood pressure, and maternal and fetal lipidsClinical Science, 2006
- Supplementation of n-3 fatty acids during pregnancy and lactation reduces maternal plasma lipid levels and provides DHA to the infantsThe Journal of Maternal-Fetal & Neonatal Medicine, 2006
- The relationship between folate and docosahexaenoic acid in menEuropean Journal of Clinical Nutrition, 2005
- Effects of n-3 polyunsaturated fatty acid supplementation in pregnancy on maternal and fetal erythrocyte fatty acid compositionEuropean Journal of Clinical Nutrition, 2004
- Maternal docosahexaenoic acid supplementation and fetal accretionBritish Journal of Nutrition, 2003
- Serum lipid, apolipoprotein and lipoparticle levels in the human fetusPrenatal Diagnosis, 1995